Metformin Promotes Osteogenic Differentiation of Adipose‐Derived Stem Cells in Diabetic Osteoporosis by Regulating Autophagy
Cell Biology International · 2025
DOI: 10.1002/cbin.70061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2025. Verfasst von Huayue Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Implantology, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Metformin, Autophagy, Osteogenesis, Osteoporosis. Die Arbeit nennt 57 Literaturangaben. Gefördert von: This study was supported by National Natural Science Foundation of China (82370938, 81870746), Project of Science & Technology Department of Sichuan Province (….
Abstract (Originalsprache)
Patients with diabetic osteoporosis (DOP) face significant challenges in bone defect repair and regeneration. Adipose‐derived stem cells (ASCs) have been widely used in bone tissue engineering due to their accessibility and multi‐potency. However, DOP‐ASCs exhibit lower capacity for osteogenic differentiation compared to control ASCs (CON‐ASCs). In this study, we explored the effects of metformin (Met) on the autophagy and osteogenic capacity of DOP‐ASCs. DOP mouse model was established with a high‐fat and high‐glucose diet combined with streptozotocin injection. After treating DOP‐ASCs with Met and 3‐methyladenine (3‐MA), changes in autophagy levels and osteogenic differentiation capacity were observed by western blot analysis, real‐time quantitative PCR (qPCR), immunofluorescence, alkaline phosphatase staining, alizarin red staining, and GFP‐LC3 fluorescence labeling analysis. DOP‐ASCs were cocultured with the Biphasic Calcium Phosphate (BCP), and implanted into the cranial defect area of DOP mice. The mice then received oral Met and intraperitoneal 3‐MA injections for 3 months. The implanted BCP was assessed by micro‐CT, HE and Masson staining. We observed a significantly reduced autophagic levels and capacity for osteogenic differentiation in DOP‐ASCs, as compared to CON‐ASCs. Met activated autophagy in DOP‐ASCs and improved their osteogenic differentiation capacity. However, in the DOP + Met + 3MA group, both the autophagic level and the osteogenic differentiation capacity were suppressed. The results from the in vitro research and the in vivo outcomes agreed. Moreover, Met dramatically reduced p‐PI3K and p‐AKT expression. Met improves the osteogenic differentiation capacity by activating autophagy, an effect mediated through the PI3K/AKT signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Implantology, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.
- Department of Oral and Maxillofacial Surgery, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.
- Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Luzhou, China.
- Institute of Stomatology, Southwest Medical University, Luzhou, China.
ORCID-Profile: Jingang Xiao
Förderung
- This study was supported by National Natural Science Foundation of China (82370938, 81870746), Project of Science & Technology Department of Sichuan Province (…
Zitieren
APA
Cao, H., Li, Q., Gao, Y., Li, J., Yu, P., Lan, X., Peng, S., & Xiao, J. (2025). Metformin Promotes Osteogenic Differentiation of Adipose‐Derived Stem Cells in Diabetic Osteoporosis by Regulating Autophagy. Cell Biology International. https://doi.org/10.1002/cbin.70061
Vancouver
Cao H, Li Q, Gao Y, Li J, Yu P, Lan X, et al. Metformin Promotes Osteogenic Differentiation of Adipose‐Derived Stem Cells in Diabetic Osteoporosis by Regulating Autophagy. Cell Biology International. 2025. doi:10.1002/cbin.70061
BibTeX
@article{Cao2025,
author = {Cao, Huayue and Li, Qilin and Gao, Yujin and Li, Jingxiang and Yu, Peiyang and Lan, Xiaorong and Peng, Shuanglin and Xiao, Jingang},
title = {Metformin Promotes Osteogenic Differentiation of Adipose‐Derived Stem Cells in Diabetic Osteoporosis by Regulating Autophagy},
journal = {Cell Biology International},
year = {2025},
doi = {10.1002/cbin.70061}
}
EUVIMED